VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most universal liver diseases with complicated pathogenesis throughout the world. Insulin resistance is a leading risk factor that contributes to the development of NAFLD. Vascular endothelial growth factor B (VEGFB) was des...
Zapisane w:
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2024-10-01
|
| Seria: | Journal of Translational Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12967-024-05621-w |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|